It just may be those who bought at .18 are bailing out. I can't understand the secrecy around working with a large pharma co in developing additional N Assay products. Why not put out the name. What would be the harm and to who? The only thing I can suggest is that in the event of failure they don't want to show any association with the company. I expect if successful the name will have to come out. Having a contract, I'd think the company would want all to know specifically who they are working with. Having a contract is very different than sending out product in mass to be tested by a host of different companies. As long as the company keeps us informed that a commitment continues, that would be ok without being specific. In the past to many associations have been left to die on the vine without a word. News of the planned expansion does indicate progress is being made. The company would not expand if there wasn't a very good chance of success. There should be a significant amount of news in the coming year. Maybe the expansion financing is being done by way of warrants.